Validation of a risk assessment instrument for pulmonary arterial hypertension

被引:14
|
作者
Weatherald, Jason [1 ,2 ,3 ,4 ]
Sitbon, Olivier [2 ,3 ,4 ]
Humbert, Marc [2 ,3 ,4 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Med, Div Respirol, Calgary, AB, Canada
[2] Univ Paris Saclay, Fac Med, Univ Paris Sud, Le Kremlin Bicetre, France
[3] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
[4] Hop Marie Lannelongue, INSERM UMR S 999, Le Plessis Robinson, France
关键词
COMBINATION THERAPY; PREVALENT COHORTS; AMBRISENTAN; TADALAFIL; SURVIVAL; INCIDENT; REGISTRY;
D O I
10.1093/eurheartj/ehx301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:4182 / 4185
页数:4
相关论文
共 50 条
  • [1] Risk assessment in pulmonary arterial hypertension
    Raina, Amresh
    Humbert, Marc
    [J]. EUROPEAN RESPIRATORY REVIEW, 2016, 25 (142): : 390 - 398
  • [2] Risk assessment in pulmonary arterial hypertension
    Boucly, Athenais
    Weatherald, Jason
    Humbert, Marc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [3] Risk Assessment in Pulmonary Arterial Hypertension
    Hoeper, M.
    Pittrow, D.
    Opitz, C. F.
    Gibbs, J.
    Rosenkranz, S.
    Gruenig, E.
    Olsson, K.
    Huscher, D.
    Delcroix, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Humbert, Marc
    Farber, Harrison W.
    Ghofrani, Hossein-Ardeschir
    Benza, Raymond L.
    Busse, Dennis
    Meier, Christian
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [5] A Modified Risk Assessment Score for Pulmonary Arterial Hypertension
    Xiong, W.
    Xu, M.
    Wang, L.
    Guo, J.
    Liu, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Noninvasive Assessment of Murine Pulmonary Arterial Pressure Validation and Application to Models of Pulmonary Hypertension
    Thibault, Helene B.
    Kurtz, Baptiste
    Raher, Michael J.
    Shaik, Rahamthulla S.
    Waxman, Aaron
    Derumeaux, Genevieve
    Halpern, Elkan F.
    Bloch, Kenneth D.
    Scherrer-Crosbie, Marielle
    [J]. CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (02) : 157 - 163
  • [7] Design and validation of a physiological risk score for pulmonary arterial hypertension (pah)
    Middleton, Jennifer
    Elliot, Charlie
    Pearson, Charlotte
    Battersby, Christian
    Roman, Stefan
    Armstrong, Iain
    Condliffe, Robin
    Watson, Lisa
    Rothman, Alexander M. K.
    Neelam-Naganathan, Dharshan
    Kiely, David G.
    Reddy, Ashwin
    Zafar, Hamza
    Taylor, Jake
    Roddis, Chloe
    Ashraf, Cameron
    Lewis, Robert
    Binmahfooz, Sarah
    Swift, Andy J.
    Toshner, Mark
    Dick, Jennifer
    Hamilton, Neil
    Varian, Frances
    Hameed, Abdul
    Durrington, Charlotte
    Hurdman, Judith
    Dwivdi, Krit
    Patel, Junaid
    Charalampopoulos, Athanasios
    Ablott, Jenna
    Thompson, Roger
    [J]. HEART, 2023, 109 : A156 - A159
  • [8] Risk assessment in Scleroderma-associated pulmonary arterial hypertension
    Mercurio, Valentina
    Diab, Nermin
    Peloquin, Grace
    Housten-Harris, Traci
    Damico, Rachel
    Kolb, Todd M.
    Mathai, Stephen C.
    Hassoun, Paul M.
    [J]. VASCULAR PHARMACOLOGY, 2020, 132
  • [9] Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    Boucly, Athenais
    Weatherald, Jason
    Savale, Laurent
    Jais, Xavier
    Cottin, Vincent
    Prevot, Gregoire
    Picard, Francois
    de Groote, Pascal
    Jevnikar, Mitja
    Bergot, Emmanuel
    Chaouat, Ari
    Chabanne, Celine
    Bourdin, Arnaud
    Parent, Florence
    Montani, David
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [10] Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
    Olsson, Karen M.
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (04)